Physician profile
Mahmoud Alsayed
NPI 1215288568
$2,475.97
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $793 · 2020: $141 · 2021: $463 · 2022: $918 · 2023: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $161.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $370.61 | 2019-2022 | |
| Inari Medical, INC. | $347.01 | 2021-2022 | |
| Abbott Laboratories | $237.25 | 2019-2023 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $214.93 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $211.20 | 2019-2022 | |
| Mannkind Corporation | $205.91 | 2019-2020 | |
| Ascensia Diabetes Care US INC. | $117.49 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $117.38 | 2021 | |
| Lilly USA, LLC | $116.34 | 2019-2022 | |
| Insulet Corporation | $74.02 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $55.47 | 2019 | |
| Radius Health, INC. | $53.06 | 2021 | |
| Abbvie INC. | $50.95 | 2019-2020 | |
| Lifescan, INC. | $44.75 | 2019-2020 | |
| Dexcom, INC. | $42.73 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $37.60 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $33.74 | 2019 | |
| Shire North American Group INC | $26.14 | 2019 | |
| Horizon Therapeutics Plc | $22.48 | 2022 | |
| Xeris Pharmaceuticals, INC. | $19.03 | 2021 | |
| Tandem Diabetes Care, INC. | $17.60 | 2019 | |
| Corcept Therapeutics | $15.64 | 2022 | |
| Amgen INC. | $15.63 | 2020 | |
| Merck Sharp & Dohme LLC | $14.84 | 2020 | |
| Allergan, INC. | $14.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mahmoud Alsayed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.